PT  - JOURNAL ARTICLE
AU  - Tahseen A Chowdhury
AU  - Paul Grant
TI  - Drug therapies in type 2 diabetes: an era of personalised medicine
AID  - 10.7861/clinmedicine.16-5-441
DP  - 2016 Oct 01
TA  - Clinical Medicine
PG  - 441--447
VI  - 16
IP  - 5
4099  - http://www.rcpjournals.org/content/16/5/441.short
4100  - http://www.rcpjournals.org/content/16/5/441.full
SO  - Clin Med2016 Oct 01; 16
AB  - Optimal management of diabetes involves a multidisciplinary approach. Prioritisation of lifestyle change, blood pressure and lipid control, and regular screening for complications are advocated in most international guidelines. Good glucose control, however, remains an important aim of treatment, although it is increasingly recognised that glucose targets should be individualised, with less stringent targets for older patients with significant comorbidities.In recent years, a number of newer therapies for hyperglycaemia have become available. This review aims to discuss currently available options for patients with type 2 diabetes, and also discusses potential new therapies that may be on the horizon in the future.